Lyell Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Jounce Therapeutics.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Jounce Therapeutics
Jounce Therapeutics
Jounce Therapeutics is a clinical-stage immunotherapy company.
Founding Date
Founding Date
2018
Founding Date
2013
Type
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Cambridge, US HQ
Employees
Employees
188
Employees
1302% increase
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
101.6 m

Financial

Net income
Net income
($274.4m) (FY, 2025)
Net income
($50.9m) (FY, 2022)
For sources of this data, please see the company profile

View Company Profiles

Jounce Therapeutics
HQ
Cambridge, US
Employees
130↑ 2% increase

Jounce Therapeutics is a clinical-stage immunotherapy company.

View company